Navigation Links
Blood Pressure Pill Combo More Effective Than Diuretics
Date:12/3/2008

Study suggests need to change therapeutic guidelines,,,,

WEDNESDAY, Dec. 3 (HealthDay News) -- A pill that contains two blood pressure drugs was more effective than a diuretic-based strategy in reducing the risk of serious cardiovascular problems and death in people with high blood pressure, according to a study that included more than 11,000 patients in the United States, Sweden, Norway, Denmark and Finland.

The patients took either a tablet containing benazepril (an ACE inhibitor) and amlodipine (a calcium channel blocker) or a tablet that contained benazepril and hydrochloro-thiazide, a type of diuretic (water pill). Both combination pills helped reduce blood pressure in more than 75 percent of patients, but those taking the first pill had 20 percent fewer cardiovascular events than those taking the other combination pill with the diuretic. The study defined cardiovascular events as cardiovascular deaths, heart attacks, strokes, hospitalization for unstable angina, and treatments to reopen blocked heart arteries.

The Avoiding Cardiovascular Events Through Combination Therapy in Patients Living with Systolic Hypertension (ACCOMPLISH) study was published in the Dec. 4 issue of the New England Journal of Medicine.

The results were so significant that the trial was stopped early, said the authors of the study, which was funded by Novartis, one of the companies that offer two-drug tablets for treatment of high blood pressure. The researchers said the findings suggest the need to change current blood pressure control guidelines, which call for initial treatment with a diuretic, with other drugs added only as needed to lower blood pressure.

"This robust study showed us that switching patients to a single-pill combination meant that twice as many patients got to their blood pressure goal, regardless of previous therapy," study leader Dr. Kenneth Jamerson, a professor of internal medicine at the University of Michigan Medical School and a member of the U-M Cardiovascular Center, said in a university news release.

"The significant reduction in cardiovascular events we observed in patients will, I hope, show physicians that earlier use of a combination medicine, especially with amlodipine, may be in the best interest of the patients," Jamerson said.

As many as 73 million Americans have high blood pressure, which increases the risk of stroke, heart attack, heart failure and other health problems. Drugs can help control blood pressure, but many patients have trouble taking the multiple medications they need, which is why combination pills were developed, according to background information in the news release about the study.

More information

The American Heart Association has more about blood pressure-lowering drugs.



-- Robert Preidt



SOURCE: University of Michigan Health System, news release, Dec. 3, 2008


'/>"/>
Copyright©2008 ScoutNews,LLC.
All rights reserved  

Related medicine news :

1. UCLA scientists prove endothelial cells give rise to blood stem cells
2. Global Med Technologies(R) European Subsidiary to Provide Strategic Blood Transfusion Software for 21 Paris Hospitals
3. Stanford blood scanner detects even faint indicators of cancer
4. Older Adults Who Exercise Boost Blood Flow in Brain
5. Preemies Low Blood Pressure Linked to SIDS
6. Potassium loss from blood pressure drugs may explain higher risk of adult diabetes
7. Continuous Blood Pressure Monitoring Predicts Risks
8. Gulf Coast Hospital Chooses Global Med Technologies(R) Blood System
9. High Blood Pressure Stalks Many Americans
10. New Study Data: JANUVIA™ (sitagliptin) Significantly Reduced Blood Sugar Levels and Was Not Associated with Hypoglycemia in Elderly Patients with Type 2 Diabetes
11. A simple blood test for colon cancer
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Blood Pressure Pill Combo More Effective Than Diuretics
(Date:2/24/2017)... ... February 24, 2017 , ... An in-depth computational analysis ... University of Pittsburgh points to eight genes that may explain why susceptibility to one ... the results of a study published today in the journal npj Schizophrenia. , ...
(Date:2/24/2017)... (PRWEB) , ... February 24, 2017 , ... Healthcare ... The Medical Center at Craig Ranch building at 8080 State Highway 121, Suite 210, ... District with easy access to Highway 121. , As the practice has grown, the ...
(Date:2/24/2017)... ... February 24, 2017 , ... The International Association of Eating Disorders Professionals (iaedp) ... You See” body image mannequin art competition. Selected from 15 submissions from around the ... revealed at the 31st annual iaedp Symposium, March 22 – 26 in Las Vegas. ...
(Date:2/24/2017)... ... February 24, 2017 , ... ... once again hosted their Military Wedding Giveaway, with the winning couple announced on ... Farms with services generously donated from local vendors: A Matter of Taste, Ryan ...
(Date:2/23/2017)... , ... February 23, 2017 , ... ... with a clinician-based audience, will be participating in Rare Disease Day events, hosted ... D.C. In addition, Rare Disease Report, a website, weekly e-newsletter and quarterly publication, ...
Breaking Medicine News(10 mins):
(Date:2/23/2017)... Visiomed, the French leader in medical ... changing the landscape of healthcare with their innovative ... custom-made solutions. Recognizing the rising demand of self-monitoring ... without walls, Visiomed has launched BewellConnect, the most ... professionals that is empowering the lives of patients. ...
(Date:2/23/2017)... -- ITL Limited, ( ASX: ITD ), an innovative diversified healthcare ... ended 31 December 2016 compared with the previous corresponding period. A ... here . Highlights ... Earnings per share of 2.2 cents (Dec 2015: 1.2 ... $15.7m; up 11%) Profit before tax of $2.12m ...
(Date:2/23/2017)... , Feb. 23, 2017 Research and ... Analysis and Strategies - 2016" report to their offering. ... The latest research ... data and benchmarks in the global Fibromyalgia market. The ... the key drugs marketed for Fibromyalgia and their clinical attributes? How ...
Breaking Medicine Technology: